Skip to content
10-Q

Quarterly Report

Satsuma Pharmaceuticals, Inc.

0001564590-22-036617

← back to feed
Filed
Nov 3, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Oct 31, 2022 33.13M sh
Shares Diluted Q3 2022 · Sep 30, 2022 31.86M sh
Shares Diluted Q3 2022 · Sep 30, 2022 31.65M sh
Shares Diluted Q3 2022 · Sep 30, 2021 31.53M sh
Shares Diluted Q3 2022 · Sep 30, 2021 28.38M sh
Capex Q3 2022 · Sep 30, 2022 $335K
Capex Q3 2022 · Sep 30, 2021 $2M
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$39.42M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$29.4M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $40.56M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $15.84M
Stockholders Equity Q3 2022 · Sep 30, 2022 $68.38M
Stockholders Equity Q3 2022 · Jun 30, 2022 $72.19M
Stockholders Equity Q3 2022 · Mar 31, 2022 $86.98M
Stockholders Equity Q3 2022 · Dec 31, 2021 $101.34M
Stockholders Equity Q3 2022 · Sep 30, 2021 $115.67M
Stockholders Equity Q3 2022 · Jun 30, 2021 $127.74M
Stockholders Equity Q3 2022 · Mar 31, 2021 $138.15M
Stockholders Equity Q3 2022 · Dec 31, 2020 $71.94M
Current Liabilities Q3 2022 · Sep 30, 2022 $6.66M
Current Liabilities Q3 2022 · Dec 31, 2021 $8.49M
Total Liabilities Q3 2022 · Sep 30, 2022 $6.66M
Total Liabilities Q3 2022 · Dec 31, 2021 $8.49M
Current Assets Q3 2022 · Sep 30, 2022 $67.56M
Current Assets Q3 2022 · Dec 31, 2021 $99.85M
Total Assets Q3 2022 · Sep 30, 2022 $75.04M
Total Assets Q3 2022 · Dec 31, 2021 $109.83M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.48
Eps Diluted Q3 2022 · Sep 30, 2022 −$1.48
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.42
Eps Diluted Q3 2022 · Sep 30, 2021 −$1.26
Eps Basic Q3 2022 · Sep 30, 2022 −$0.48
Eps Basic Q3 2022 · Sep 30, 2022 −$1.48
Eps Basic Q3 2022 · Sep 30, 2021 −$0.42
Eps Basic Q3 2022 · Sep 30, 2021 −$1.26
Sga Expense Q3 2022 · Sep 30, 2022 $4.07M
Sga Expense Q3 2022 · Sep 30, 2022 $11.96M
Sga Expense Q3 2022 · Sep 30, 2021 $3.16M
Sga Expense Q3 2022 · Sep 30, 2021 $9.84M
Rd Expense Q3 2022 · Sep 30, 2022 $11.34M
Rd Expense Q3 2022 · Sep 30, 2022 $35.39M
Rd Expense Q3 2022 · Sep 30, 2021 $10.17M
Rd Expense Q3 2022 · Sep 30, 2021 $25.77M
Net Income Q3 2022 · Sep 30, 2022 −$15.14M
Net Income Q3 2022 · Sep 30, 2022 −$46.93M
Net Income Q3 2022 · Jun 30, 2022 −$16.27M
Net Income Q3 2022 · Mar 31, 2022 −$15.52M
Net Income Q3 2022 · Sep 30, 2021 −$13.33M
Net Income Q3 2022 · Sep 30, 2021 −$35.62M
Net Income Q3 2022 · Jun 30, 2021 −$11.83M
Net Income Q3 2022 · Mar 31, 2021 −$10.46M
Operating Income Q3 2022 · Sep 30, 2022 −$15.41M
Operating Income Q3 2022 · Sep 30, 2022 −$47.36M
Operating Income Q3 2022 · Sep 30, 2021 −$13.33M
Operating Income Q3 2022 · Sep 30, 2021 −$35.61M
Short Term Debt Q3 2022 · Dec 31, 2021 $1.08M